Jefferies Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2M Sell
74,627
-34,598
-32% -$8.06M 0.12% 135
2025
Q4
$22.6M Buy
109,225
+10,805
+11% +$2.14M 0.12% 177
2025
Q3
$18.2M Buy
98,420
+8,119
+9% +$1.39M 0.09% 158
2025
Q2
$13.8M Buy
90,301
+47,929
+113% +$7.37M 0.12% 131
2025
Q1
$7.03M Sell
42,372
-580,794
-93% -$90.9M 0.06% 216
2024
Q4
$90.1M Buy
623,166
+471,723
+311% +$73.1M 0.54% 29
2024
Q3
$24.5M Sell
151,443
-13,807
-8% -$2.2M 0.18% 73
2024
Q2
$24.2M Sell
165,250
-35,438
-18% -$5.27M 0.26% 60
2024
Q1
$31.7M Buy
200,688
+159,398
+386% +$25.4M 0.29% 51
2023
Q4
$6.47M Sell
41,290
-3,267
-7% -$501K 0.04% 326
2023
Q3
$6.94M Buy
44,557
+10,094
+29% +$1.67M 0.06% 254
2023
Q2
$5.7M Sell
34,463
-86,352
-71% -$13.9M 0.05% 325
2023
Q1
$18.7M Buy
120,815
+46,262
+62% +$7.47M 0.15% 115
2022
Q4
$13.2M Buy
+74,553
New +$12.9M 0.09% 176

Other funds holding JNJ

Jefferies Financial Group's JNJ Position: Q1 2026 in Review

Jefferies Financial Group reduced its Johnson & Johnson (JNJ) stake by 32% in Q1 2026, selling an estimated $8.06M and leaving 74,627 shares worth $18.2M. The position accounts for 0.12% of the portfolio, ranked #135.

Jefferies Financial Group first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $90.1M in Q4 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Jefferies Financial Group held 74,627 shares of Johnson & Johnson worth $18.2M as of Q1 2026.
  • Jefferies Financial Group sold 34,598 Johnson & Johnson shares in Q1 2026, an estimated $8.06M.
  • Johnson & Johnson made up 0.12% of Jefferies Financial Group's portfolio in Q1 2026, its #135 holding.
  • Jefferies Financial Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Johnson & Johnson position peaked at $90.1M in Q4 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.